Zurex PharmAgra launches antimicrobial formulation
The ZuraLac product is a non-iodine based sanitizer targeting dairy mastitis and has been developed to prevent healthcare acquired infections in hospitals and healthcare settings. The company said
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
KRN5500 is a non-narcotic, non-opioid, analgesic agent produced by Streptomyces alanosinicus. According to the Phase II, double-blind, placebo-controlled, randomized, dose escalation study, KRN5500 showed significant improvement in the